Bestore vs Danone SA: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Bestore Co Ltd (603719.CG)

Q3 202613 Jul – 24 Aug 2026

▲2▼2

Bestore swings to profit as turnaround takes hold, but big shareholders keep selling

First-half profit confirms turnaround Bestore reported a first-half net profit of 16.19 million yuan, reversing a loss, with revenue up 11.18% to 3.145 billion yuan. The company says product mix, channel efficiency and supply-chain upgrades are working. This is the clearest sign yet that the business is recovering, which supports the share price.
It is the period's biggest positive fundamental event and directly answers what is driving the stock.
Early profit forecast set the stage In mid-July, Bestore guided that it would swing to a first-half profit of 16–24 million yuan, versus a loss a year earlier, thanks to higher revenue and gross margin. The forecast primed investors for the recovery that the later results confirmed.
It is the first concrete signal of the profit turnaround and explains the positive shift in sentiment.
Major shareholders keep selling Two large shareholders cut their stakes in July: Dayong Limited sold 8.73 million shares, and Davy Limited sold 11.94 million shares for 103 million yuan. Continued selling by big owners can pressure the share price and makes some investors question their confidence in the company.
It is the main negative force this period and a real counterweight to the improving earnings.
Weak cash returns and slow new-store rollout Bestore said interest income fell 80% because deposit rates dropped, and its 934 million yuan of wealth-management products produced no disposal gains. Its new Fresh Life supermarket format still has only one pilot store. Both point to weak cash returns and slow expansion beyond the core snack business.
It highlights financial and growth weaknesses that could limit the recovery story.

August 202613 Jul – 24 Aug 2026

▲2▼2

Bestore swings to profit as turnaround takes hold, but big shareholders keep selling

First-half profit confirms turnaround Bestore reported a first-half net profit of 16.19 million yuan, reversing a loss, with revenue up 11.18% to 3.145 billion yuan. The company says product mix, channel efficiency and supply-chain upgrades are working. This is the clearest sign yet that the business is recovering, which supports the share price.
It is the period's biggest positive fundamental event and directly answers what is driving the stock.
Early profit forecast set the stage In mid-July, Bestore guided that it would swing to a first-half profit of 16–24 million yuan, versus a loss a year earlier, thanks to higher revenue and gross margin. The forecast primed investors for the recovery that the later results confirmed.
It is the first concrete signal of the profit turnaround and explains the positive shift in sentiment.
Major shareholders keep selling Two large shareholders cut their stakes in July: Dayong Limited sold 8.73 million shares, and Davy Limited sold 11.94 million shares for 103 million yuan. Continued selling by big owners can pressure the share price and makes some investors question their confidence in the company.
It is the main negative force this period and a real counterweight to the improving earnings.
Weak cash returns and slow new-store rollout Bestore said interest income fell 80% because deposit rates dropped, and its 934 million yuan of wealth-management products produced no disposal gains. Its new Fresh Life supermarket format still has only one pilot store. Both point to weak cash returns and slow expansion beyond the core snack business.
It highlights financial and growth weaknesses that could limit the recovery story.

Latest13 Jul – 24 Aug 2026

▲2▼2

Bestore swings to profit as turnaround takes hold, but big shareholders keep selling

First-half profit confirms turnaround Bestore reported a first-half net profit of 16.19 million yuan, reversing a loss, with revenue up 11.18% to 3.145 billion yuan. The company says product mix, channel efficiency and supply-chain upgrades are working. This is the clearest sign yet that the business is recovering, which supports the share price.
It is the period's biggest positive fundamental event and directly answers what is driving the stock.
Early profit forecast set the stage In mid-July, Bestore guided that it would swing to a first-half profit of 16–24 million yuan, versus a loss a year earlier, thanks to higher revenue and gross margin. The forecast primed investors for the recovery that the later results confirmed.
It is the first concrete signal of the profit turnaround and explains the positive shift in sentiment.
Major shareholders keep selling Two large shareholders cut their stakes in July: Dayong Limited sold 8.73 million shares, and Davy Limited sold 11.94 million shares for 103 million yuan. Continued selling by big owners can pressure the share price and makes some investors question their confidence in the company.
It is the main negative force this period and a real counterweight to the improving earnings.
Weak cash returns and slow new-store rollout Bestore said interest income fell 80% because deposit rates dropped, and its 934 million yuan of wealth-management products produced no disposal gains. Its new Fresh Life supermarket format still has only one pilot store. Both point to weak cash returns and slow expansion beyond the core snack business.
It highlights financial and growth weaknesses that could limit the recovery story.

Danone SA (BN.PA)

Q3 202622 Jun – 4 Sep 2026

▲4

Danone buys growth brands, beats Q2, strengthens patent

Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.
A concrete deal that adds growth and profit, directly supporting the stock.
Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.
The quarter's results beat expectations and confirm the company is on track.
Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.
A completed deal that expands a fast-growing part of the business.
New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.
Protects a promising new product line, a real positive for future sales.

July 202622 Jun – 4 Sep 2026

▲4

Danone buys growth brands, beats Q2, strengthens patent

Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.
A concrete deal that adds growth and profit, directly supporting the stock.
Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.
The quarter's results beat expectations and confirm the company is on track.
Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.
A completed deal that expands a fast-growing part of the business.
New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.
Protects a promising new product line, a real positive for future sales.

Latest22 Jun – 4 Sep 2026

▲4

Danone buys growth brands, beats Q2, strengthens patent

Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.
A concrete deal that adds growth and profit, directly supporting the stock.
Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.
The quarter's results beat expectations and confirm the company is on track.
Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.
A completed deal that expands a fast-growing part of the business.
New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.
Protects a promising new product line, a real positive for future sales.